UPM Annual Report 2015
UPM Annual Report 2015
103
104
contents
accounts
IN BRIEF
STRATEGY
BUSINESSES
STAKEHOLDERS
GOVERNANCE
ACCOUNTS
Fair value estimation
The different levels of fair value hierarchy used in fair value estimation
have been defined as follows:
Level 1: quoted prices (unadjusted) in active markets for identical
assets or liabilities.
Level 2: inputs other than quoted prices included within level 1 that
are observable for the asset or liability, either directly (that is, as
prices) or indirectly (that is, derived from prices).
Level 3: inputs for the asset or liability that are not based on
observable market data (that is, unobservable inputs).
The fair values of commodity derivatives traded in active markets
are based on quoted market rates and included in Level 1.
Fair values of Level 2 financial instruments (e.g. over-the counter
derivatives) have been estimated as follows: Interest forward rate
agreements and futures contracts are fair valued based on quoted mar-
ket rates on the balance sheet date; forward foreign exchange con-
tracts are fair valued based on the contract forward rates in effect on
the balance sheet date; foreign currency options are fair valued based
on quoted market rates on the balance sheet date; interest and cur-
rency swap agreements are fair valued based on discounted cash
flows; and commodity derivatives are fair valued based on quoted
market rates on the balance sheet date. The fair values of non-traded
derivatives such as embedded derivatives are assessed by using valua-
tion methods and assumptions that are based on market quotations
existing at each balance sheet date. Embedded derivatives that are
identified are monitored by the Group and the fair value changes are
reported in other operating income in the income statement.
The Group's fair valuation procedures and processes are set by
the Group management. Fair valuations are performed quarterly by
respective business areas or functions. Fair valuations are reviewed by
the Group’s Finance & Control management and overseen by the Audit
Committee.
Available-for-sale investments categorised in Level 3 are disclosed
in Note 22 and biological assets categorised in Level 3 in Note 20.
The following table analyses financial instruments carried at fair
value, by valuation method.
Financial assets and liabilities measured at fair value
Fair values as at 31 December 2015
EURm
Level 1 Level 2 Level 3
Total
balance
Assets
Trading derivatives
6 63
–
69
Derivatives used for hedging
88 283
– 371
Available-for-sale investments
–
– 2,085 2,085
At 31 Dec.
94 346 2,085 2,525
Liabilities
Trading derivatives
59 62
– 121
Derivatives used for hedging
109 89
– 198
At 31 Dec.
168 151
– 319
Fair values as at 31 December 2014
EURm
Level 1 Level 2 Level 3
Total
balance
Assets
Trading derivatives
1 61
–
62
Derivatives used for hedging
52 328
– 380
Available-for-sale investments
–
– 2,510 2,510
At 31 Dec.
53 389 2,510 2,952
Liabilities
Trading derivatives
22 111
– 133
Derivatives used for hedging
81 156
– 237
At 31 Dec.
103 267
– 370
There have been no transfers between levels.
The following table presents the changes in Level 3 instruments
for the year ended 31 December 2015
EURm
Available-
for-sale
investments
Opening balance
2,510
Additions
33
Disposals
–35
Transfers into Level 3
1
Gains and losses
Recognised in statement of comprehensive income,
under available-for-sale investments
–424
Closing balance
2,085
The following table presents the changes in Level 3 instruments
for the year ended 31 December 2014
EURm
Available-
for-sale
investments
Opening balance
2,661
Additions
31
Disposals
–1
Transfers from Level 3
–10
Translation differences
2
Gains and losses
Recognised in statement of comprehensive income,
under available-for-sale investments
–173
Closing balance
2,510
4 Segment Information
The Group’s management has determined the operating segments
based on management reporting regularly reviewed by the Group’s
chief operating decision maker. The chief operating decision maker
has been identified as the Group’s President and CEO.
The operating segments are organised on a product basis.
UPM’s business structure consists of the following business areas
and reporting segments: UPM Biorefining, UPM Energy,
UPM Raflatac, UPM Paper Asia, UPM Paper ENA (Europe and North
America) and UPM Plywood. Wood sourcing and forestry, UPM Bio-
composites, UPM Biochemicals business units and Group services are
reported in Other operations.
Reportable segments
UPM Biorefining
UPM Biorefining consists of pulp, timber and biofuels businesses. UPM
has three pulp mills in Finland, one pulp mill and plantation operations
in Uruguay and four sawmills in Finland. UPM’s biorefinery for produc-
ing wood-based renewable diesel has started up in January 2015 in
Finland.
UPM Energy
UPM Energy operates in power generation and physical and deriva-
tives trading. The segment consists of UPM’s hydro power assets in
Finland and shareholdings in energy companies.
UPM Raflatac
UPM Raflatac manufactures self-adhesive label materials for product
and information labelling.
UPM Paper Asia
UPM Paper Asia consists of UPM Changshu paper mill in China and
label paper operations in the Tervasaari and Jämsänkoski mills in
Finland.
UPM Paper ENA
UPM Paper ENA produces magazine paper, newsprint and fine paper
in Europe and North America.
UPM Plywood
UPM Plywood produces plywood and veneer products in Finland,
Estonia and Russia.
Other operations
Other operations include wood sourcing and forestry, UPM Bio-
composites, UPM Biochemicals business units and Group services.
The information reported for each segment is the measure of what the
Group’s President and CEO uses internally for evaluating segment
performance and deciding on how to allocate resources to operating
segments.
The performance of an operating segment is evaluated primarily
based on the segment’s operating profit. The joint operation Madison
Paper Industries (MPI) is reported as subsidiary in UPM Paper ENA
reporting. In addition, the changes in fair value of unrealised commod-
ity hedges are not allocated to segments. Otherwise the segment’s
operating profit is measured on a basis consistent with the consoli-
dated financial statements. Sales between the segments are based on
market prices.
The amounts provided to the President and CEO in respect of seg-
ment assets and liabilities are measured on a basis consistent with con-
solidated financial statements. Assets and liabilities are allocated to the
segments based on segment operations. Unallocated assets and liabili-
ties comprise other than energy shares under available-for-sale invest-
ments, non-current financial assets, deferred tax assets and liabilities,
other non-current assets, income tax receivables and payables, cash
and cash equivalents, assets classified as held for sale and related
liabilities, retirement benefit obligations, provisions, interest-bearing
liabilities and other liabilities and payables.